FOYA winners announced
Six pharmaceutical manufacturing facilities in Europe and the US win award categories
Pfizer Health won the Facility of the Year Award for Operational Excellence at its Project Pegasus – Bio 7 manufacturing facility in Strängnäs, Sweden. This microbial drug substance production plant manufactures two legacy Pfizer hormone treatments, Genotropin and Somavert. Pfizer scientists developed a manufacturing process with virtually identical unit operations that could be used for both products.
Project Pegasus won this category for Pfizer’s ability to bring a new facility online with added capacity without increasing staff numbers or extending shift patterns. This was achieved by incorporating a high degree of flexibility into the facility design. The project team also minimised manual interactions in the process.
Control system recipes were developed that enhanced the efficiency of this biotech operation. Targeted output of the facility was previously 2 batches per week, but as a result of their focus on Operational Excellence, the facility currently has the capacity to produce 3.5 batches per week.
F. Hoffman – La Roche took the Process Innovation category award for its “MyDose” clinical supply facility in Kaiseraugst, Switzerland.
MedImmune won for Project Execution at its Frederick Manufacturing Center (FMC) expansion facility in Frederick, Maryland, US, while the Facility Integration category award went to Merck and Company for its Global Clinical Supplies Manufacturing, Packaging and Warehouse expansion project in Summit, New Jersey, US.
Novartis Vaccines and Diagnostics took the Equipment Innovation category award for its “MARS Project” facility in Marburg, Germany.
The sixth winner was Pfizer Manufacturing Deutschland, which won the Sustainability category for its SPRING & E-MAP (Strategic Plant Restructuring & Energy Master Plan) project in Freiburg, Germany.
Shire HGT received an Honourable Mention for its Project Atlas, Building 400 facility in Lexington, Massachusetts, US.
Now in its seventh year, the Facility of the Year Awards, sponsored by ISPE, Interphex and Pharmaceutical Processing magazine in the US, recognise state-of-the-art pharmaceutical manufacturing projects that incorporate new and innovative technologies to enhance the delivery of a quality project, as well as reduce the cost of producing medicines.
The Overall Facility of the Year award will be presented during ISPE’s 2011 Annual Meeting, which takes place from 6–9 November in Grapevine, Texas, US.
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
Read moreAt Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model
Manufacturing
BioNTech to cut up to 1860 jobs and end COVID vaccine production in Germany
The German biotech has announced it will cease production at its manufacturing sites in Germany and Singapore in its Q1 earnings report, cutting up to 22% of its workforce in the process as it pivots from COVID-19 vaccines to oncology